Project Details
Description
A Phase 1b Study to Evaluate the Safety, Tolerability and Drug-Drug Interactions of ANX005 and Intravenous Immunoglobulin (IVIg) in Subjects with Guillain-Barre Syndrome
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/19 → 9/30/22 |
Funding
- ANNEXON, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.